Antithrombin Market To Report Impressive Growth, Revenue To Surge To US$613.8 Million By 2022

With the presence of a large pool of participants, the global antithrombin market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Grifols, rEVO Biologics Incorporation, Shire plc, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions are some of the key vendors of antithrombin across the world. These players across antithrombin market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development states the antithrombin market study.

This review is based on a report by Zion Market Research, titled “Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022.”- https://www.zionmarketresearch.com/report/antithrombin-market

Citing an instance, in July 2017, Alnylam Pharmaceuticals Incorporation—a California-based biopharmaceutical firm—declared that it will create a new agent Fitusiran (also referred as ALN-AT3SC) for treating hemophilia A or hemophilia B in adult patients during Phase 1 clinical trials. Reportedly, Fitusiran - an Investigational RNAi therapeutic- is developed to target antithrombin at its product site, namely liver, and then inhibit the activities of antithrombin, thereby helping in preventing bleeding and restoring blood clotting balance.

In another major event that is likely to influence the growth of antithrombin market, in May 2018, Dova Pharmaceuticals Incorporation declared the commercialization of DOPTELET in the United States for treating thrombocytopenia patients having the acute liver disorder and expected to undergo a surgery. Reportedly, U.S. FDA approved DOPTELET in May 2018 and it is the first drug that can be orally administered in patients for treating thrombocytopenia, according to company sources.

As estimated in this report, the global antithrombin market stood at US$ 450.4 million in 2016. Witnessing a tremendous rise during the period from 2017 to 2022, the revenue in this antithrombin market is expected to reach US$ 613.8 million by the end of the forecast period.

Rampant Product Usage In Various Medical Conditions To Succor Market Growth

“Wide spectrum of product applications in treating myriad medical conditions such as sepsis, extracorporeal membrane oxygenation, disseminated intravascular coagulation, and hereditary antithrombin deficiency are expected to favorably leverage growth of antithrombin market in the years ahead,” says the author of this antithrombin market study. Apart from this, massive use of the product in combination with heparin is anticipated to augment antithrombin market space over the next decade.

Well Established Healthcare Infrastructure To Aid European Dominance

Regionally, Europe has been leading the worldwide antithrombin market and is anticipated to continue on the dominant position in the years to come, states the antithrombin market study. Large-scale adoption of antithrombin treatments along with well-developed healthcare infrastructure facilities is the key factor behind the dominance of the European antithrombin market. In addition, immense ongoing research activities witnessed across the biopharmaceuticals sector along with the introduction of innovative technologies are few of the other significant factors supporting the growth of antithrombin market in Europe.

The global antithrombin market is segmented as follows:

By Source

• Human
• Goat Milk

By Application

• Diagnostics
• Therapeutics
• Research

By Dosage Form

• Liquid
• Lyophilized

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com